| For: |
Kim MN, Koh SJ, Kim JM, Im JP, Jung HC, Kim JS. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i45/17084.htm |
| Number | Citing Articles |
| 1 |
Lifang Wang, Ju Cao, Congya Li, Liping Zhang. IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis. The Journal of Infectious Diseases 2018; 217(2) doi: 10.1093/infdis/jix581
|
| 2 |
Deiziane V. S. Costa, Beatriz Thomasi, Gerly A. C. Brito, Brian D. Gulbransen, Cirle A. Warren. The role of the enteric nervous system in the pathogenesis of Clostridioides difficile infection. Nature Reviews Gastroenterology & Hepatology 2025; 22(8) doi: 10.1038/s41575-025-01071-x
|
| 3 |
Kevin S. Mears, Michael C. Abt, Karen M. Ottemann.
Balancing act of cytokines in controlling the severity of
Clostridioides difficile
infection
. Infection and Immunity 2026; 94(8) doi: 10.1128/iai.00551-25
|
| 4 |
Emily S. Cribas, Joshua E. Denny, Jeffrey R. Maslanka, Michael C. Abt, Nancy E. Freitag. Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection. Infection and Immunity 2021; 89(5) doi: 10.1128/IAI.00730-20
|
| 5 |
Lamei Wang, Javier A. Villafuerte Gálvez, Christina Lee, Shengru Wu, Ciaran P. Kelly, Xinhua Chen, Yangchun Cao. Understanding host immune responses in Clostridioides difficile infection: Implications for pathogenesis and immunotherapy. iMeta 2024; 3(3) doi: 10.1002/imt2.200
|
| 6 |
Imran Khan, Guoxin Huang, Xiao-ang Li, Weilin Liao, Wai Kit Leong, Wenrui Xia, Xiqing Bian, Jianlin Wu, W.L. Wendy Hsiao. Mushroom polysaccharides and jiaogulan saponins exert cancer preventive effects by shaping the gut microbiota and microenvironment in Apc mice. Pharmacological Research 2019; 148 doi: 10.1016/j.phrs.2019.104448
|
| 7 |
Katia Fettucciari, Pierfrancesco Marconi, Andrea Marchegiani, Alessandro Fruganti, Andrea Spaterna, Gabrio Bassotti. Invisible steps for a global endemy: molecular strategies adopted by Clostridioides difficile. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211032797
|
| 8 |
. 2017; doi: 10.70675/326ee41fz6420z4113z8eceze3ed4ec7fe54
|
| 9 |
Fenfen Zhou, Therwa Hamza, Ashley S Fleur, Yongrong Zhang, Hua Yu, Kevin Chen, Jonathon E Heath, Ye Chen, Haihui Huang, Hanping Feng. Mice with Inflammatory Bowel Disease are Susceptible toClostridium difficileInfection With Severe Disease Outcomes. Inflammatory Bowel Diseases 2018; 24(3) doi: 10.1093/ibd/izx059
|
| 10 |
Fu-Chen Huang. The Interleukins Orchestrate Mucosal Immune Responses to Salmonella Infection in the Intestine. Cells 2021; 10(12) doi: 10.3390/cells10123492
|
| 11 |
Deiziane V.S. Costa, Natalie Pham, Andrea V. Loureiro, Suemin E. Yang, Brian W. Behm, Cirle A. Warren. Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease. Anaerobe 2024; 87 doi: 10.1016/j.anaerobe.2024.102837
|
| 12 |
Séverine Péchiné, Anne Collignon. Immune responses induced by Clostridium difficile. Anaerobe 2016; 41 doi: 10.1016/j.anaerobe.2016.04.014
|
| 13 |
Xianrong Zhou, Huazhi Liu, Jing Zhang, Jianfei Mu, Zsolt Zalan, Ferenc Hegyi, Krisztina Takács, Xin Zhao, Muying Du. Protective effect of Lactobacillus fermentum CQPC04 on dextran sulfate sodium–induced colitis in mice is associated with modulation of the nuclear factor-κB signaling pathway. Journal of Dairy Science 2019; 102(11) doi: 10.3168/jds.2019-16840
|
| 14 |
Hao Yang, Lamei Wang, Javier A. Villafuerte Gálvez, Xinru Ma, Hua Xu, Shengru Wu, Junhu Yao, Xinhua Chen, Yangchun Cao. Clostridium difficile and gut health: Bacteria, the gut microbiome, and diet. iMetaOmics 2025; 2(1) doi: 10.1002/imo2.50
|
| 15 |
Xi Jing, Anna A. Korchagina, Sergey A. Shein, Wayne T. Muraoka, Ekaterina Koroleva, Alexei V. Tumanov. IL-23 Contributes to Campylobacter jejuni-Induced Intestinal Pathology via Promoting IL-17 and IFNγ Responses by Innate Lymphoid Cells. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.579615
|
| 16 |
José L. Fachi, Marco A. R. Vinolo, Marco Colonna. Reviewing the Clostridioides difficile Mouse Model: Insights into Infection Mechanisms. Microorganisms 2024; 12(2) doi: 10.3390/microorganisms12020273
|
| 17 |
Hua Yu, Kevin Chen, Ying Sun, Mihaela Carter, Kevin W. Garey, Tor C. Savidge, Sridevi Devaraj, Mary Elizabeth Tessier, Erik C. von Rosenvinge, Ciaran P. Kelly, Marcela F. Pasetti, Hanping Feng, Helene F. Rosenberg. Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity. Clinical and Vaccine Immunology 2017; 24(8) doi: 10.1128/CVI.00037-17
|
| 18 |
Pingping Zhang, Ruitao Mao, Zhi Lv, Baoya Wang, Jianrong Su. Critical role of MAVS in the protection against Clostridium difficile-induced colitis. Microbial Pathogenesis 2018; 125 doi: 10.1016/j.micpath.2018.09.035
|
| 19 |
Gabrio Bassotti, Alessandro Fruganti, Fabrizio Stracci, Pierfrancesco Marconi, Katia Fettucciari. Cytotoxic synergism of <i>Clostridioides difficile</i> toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases. World Journal of Gastroenterology 2023; 29(4): 582-596 doi: 10.3748/wjg.v29.i4.582
|